Skip to main content

Table 1 The clinical, pathologic, treatment characteristics in patients with stage III STS and their correlations with radiographic response

From: Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

Issues Catogaries N Radiographic response χ P
PR SD PD
Age Median 42 years   
Gender Male 67 15 39 13 −0.02 0.831
  Female 53 10 36 7   
Size(CM) Mean 10 cm   
  ≥10   5 39 19 0.453 <0.001
  <10   20 36 1   
FNCLCC grade 2 45 10 31 4 3.150 0.207
  3 75 15 44 16   
Subtype MFH 33 6 17 10 11.270 0.187
  SS 28 5 20 3   
  LS 28 8 16 4   
  LMS 16 1 13 2   
  Others 15 5 9 1   
Neo-AC cycles 1 18 7 10 3 0.832 0.374
  2 102 18 65 17   
Chemotherapy regimen MAID 80 18 50 12 0.720 0.698
  AIM 40 7 25 8   
UICC margin R0 + R1 92 24 57 11 10.491 0.005
  R2 28 1 18 9   
Follow-up(M) Median 46.0 (13–158)   
  1. PR: Partial response; SD: Stable Disease; PD: Progressive Disease; FNCLCC: French Federation of Cancer Centres; Neo-AC: Neoadjuvant chemotherapy; UICC: Union Internationale Contre Cancer; MFH: malignant fibrous histiocytoma; SS: synovial sarcoma; LS: liposarcoma; LMS: leiomyosarcoma.